USPTO serial 99819705
CAMURUS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, TEJBIR
- Law office
- TMEG LAW OFFICE 106
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with CAMURUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Kreider Gaunt
Karen Kreider Gaunt Dinsmore & Shohl LLP255 E. 5th St, Suite 1900Cincinnati, OH 45202United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; dietary supplements for human beings and animals; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | ACTIVE | — |
| 010 | Devices, namely, injection instruments with needles and injection instruments without needles for subcutaneous administration of drugs; devices, namely, injection instruments with needles and injection instruments without needles for parenteral administration of drugs; devices, namely, injection instruments with needles and injection instruments without needles for drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for subcutaneous drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for parenteral drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for administration of solution for injection; devices, namely, injection instruments with needles and injection instruments without needles for administration of drug depot injection; medical syringes for subcutaneous administration of drugs; medical syringes for parenteral administration of drugs; medical syringes for drug depot injection; medical syringes for subcutaneous drug depot injection; medical syringes for parenteral drug depot injection; medical syringes for administration of solutions for injection; medical syringes for administration of drug depot injection; medical syringes for injections; syringes for medical purposes; medical apparatus and instruments, namely, needles for medical purposes; dropping pipettes for medical purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 13, 2026 | NWAP | NEW APPLICATION ENTERED | — |